admin

Novo Nordisk Pops on Wegovy Sales

[ad_1] Shares of Novo Nordisk (NYSE:NVO) jumped on Wednesday after it said sales of its blockbuster Wegovy weight loss drug were seen improving in the second half of the year as the availability of copycat compounded drugs is phased out. The Danish pharmaceutical giant reported lower-than-expected first-quarter sales of its flagship obesity drug…

Read More

Uber Reverses on Latest Quarterly Figures

[ad_1] Uber (NASDAQ:UBER) reported first-quarter results Wednesday that beat analysts’ expectations for earnings, but fell shy of anticipated revenue growth for the quarter. Shares fell $5.15, or 6% following the report to $56.62. Earnings per share proved to be 83 cents vs. 50 cents expected. Revenue: $11.53 billion vs. $11.62 billion expected. Revenue…

Read More